메뉴 건너뛰기




Volumn 83, Issue 3, 2013, Pages 377-383

Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease?

Author keywords

blood pressure; chronic kidney disease; clinical practice guideline; evidence based recommendation; hypertension; KDIGO

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BENDROFLUMETHIAZIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; RAMIPRIL; SIMVASTATIN;

EID: 84874667042     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.425     Document Type: Review
Times cited : (147)

References (11)
  • 1
    • 84874656078 scopus 로고    scopus 로고
    • KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease
    • KDIGO Blood Pressure Work Group
    • KDIGO Blood Pressure Work Group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int 2012; 2(Suppl): 337-414
    • (2012) Kidney Int , Issue.2 SUPPL. , pp. 337-414
  • 2
    • 3042819708 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease
    • Foundation. N.K.
    • Foundation. NK. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004; 43: S1-290
    • (2004) Am J Kidney Dis , vol.43
  • 3
    • 33845343267 scopus 로고    scopus 로고
    • Grading evidence and recommendations for clinical practice guidelines in nephrology A position statement from kidney disease: Improving Global Outcomes (KDIGO)
    • Uhlig K, Macleod A, Craig J et al. Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from kidney disease: Improving Global Outcomes (KDIGO). Kidney Int 2006; 70: 2058-2065
    • (2006) Kidney Int , vol.70 , pp. 2058-2065
    • Uhlig, K.1    Macleod, A.2    Craig, J.3
  • 4
    • 70350564378 scopus 로고    scopus 로고
    • Kidney disease: Improving global outcomes
    • Eckardt KU, Kasiske BL. Kidney disease: Improving global outcomes. Nat Rev Nephrol 2009; 5: 650-657
    • (2009) Nat Rev Nephrol , vol.5 , pp. 650-657
    • Eckardt, K.U.1    Kasiske, B.L.2
  • 5
    • 79955375480 scopus 로고    scopus 로고
    • Systematic review: Blood pressure target in chronic kidney disease and proteinuria as an effect modifier
    • Upadhyay A, Earley A, Haynes SM et al. Systematic review: Blood pressure target in chronic kidney disease and proteinuria as an effect modifier. Ann Intern Med 2011; 154: 541-548
    • (2011) Ann Intern Med , Issue.154 , pp. 541-548
    • Upadhyay, A.1    Earley, A.2    Haynes, S.M.3
  • 6
    • 84874644599 scopus 로고    scopus 로고
    • KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease
    • KDIGO CKD Work Group
    • KDIGO CKD Work Group. KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 2013; 3(Suppl): 1-150
    • (2013) Kidney Int , Issue.3 SUPPL. , pp. 1-150
  • 7
    • 74949094555 scopus 로고    scopus 로고
    • KDIGO clinical practice guideline for the care of kidney transplant recipients
    • KDIGO Transplant Work Group
    • KDIGO Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009; 9(Suppl 3): S1-155
    • (2009) Am J Transplant , vol.9 , Issue.SUPPL. 3
  • 8
    • 75749131914 scopus 로고    scopus 로고
    • Blood pressure in chronic kidney disease stage 5D-report from a kidney disease: Improving Global Outcomes controversies conference
    • Levin NW, Kotanko P, Eckardt KU et al. Blood pressure in chronic kidney disease stage 5D-report from a kidney disease: Improving Global Outcomes controversies conference. Kidney Int 2010; 77: 273-284
    • (2010) Kidney Int , Issue.77 , pp. 273-284
    • Levin, N.W.1    Kotanko, P.2    Eckardt, K.U.3
  • 10
    • 84865642129 scopus 로고    scopus 로고
    • Baseline characteristics in the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE)
    • Parving HH, Brenner BM, McMurray JJ et al. Baseline characteristics in the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE). J Renin Angiotensin Aldosterone Syst 2012; 3: 387-393
    • (2012) J Renin Angiotensin Aldosterone Syst , Issue.3 , pp. 387-393
    • Parving, H.H.1    Brenner, B.M.2    McMurray, J.J.3
  • 11
    • 77950187294 scopus 로고    scopus 로고
    • Renal outcomes with different fixeddose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): A prespecified secondary analysis of a randomised controlled trial
    • Bakris GL, Sarafidis PA, Weir MR et al. Renal outcomes with different fixeddose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): A prespecified secondary analysis of a randomised controlled trial. Lancet 2010; 375: 1173-1181
    • (2010) Lancet , Issue.375 , pp. 1173-1181
    • Bakris, G.L.1    Sarafidis, P.A.2    Weir, M.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.